TSHA filings
Corporate insider profile
Sukumar Nagendran Filing Activity
Latest reported as President and Head of R&D of Taysha Gene Therapies, Inc. (TSHA).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$1,248,000.00
- Latest transaction
- Jul 10, 2026
Affiliated corporations
Reported company relationships
Transaction history
